ABPath Clinical Pathology study materials
ABPath Clinical Pathology study resources

A 58-Year-Old with Recurrent Syncope and a Normal Basic Metabolic Panel

ABPath Clinical Pathology · Put your knowledge to work in context.

All case studies

A 58-Year-Old with Recurrent Syncope and a Normal Basic Metabolic Panel

A 58-year-old woman with a history of hypertension and prediabetes is admitted after three episodes of syncope over two weeks. She takes hydrochlorothiazide and lisinopril. Vitals stable; ECG shows a prolonged QT interval (QTc 512 ms). Basic metabolic panel: sodium 141 mmol/L, potassium 3.1 mmol/L, chloride 101 mmol/L, bicarbonate 26 mmol/L, glucose 104 mg/dL, BUN 14 mg/dL, creatinine 0.9 mg/dL, calcium 9.4 mg/dL, magnesium 1.4 mg/dL (ref 1.7-2.4). The resident asks you to work up the syncope. The patient mentions she recently started a proton pump inhibitor and has been using an over-the-counter 'natural calm' powder nightly to help her sleep, and she has had two prior admissions for palpitations that resolved with IV electrolytes.

1. Interpret the electrolyte panel and explain how the findings interact to produce the ECG abnormality. What additional testing would you request before the patient is discharged?

Read the worked answer

The panel shows hypokalemia (K 3.1) and hypomagnesemia (Mg 1.4) with a normal bicarbonate/anion gap and normal renal function. This pattern is not explained by thiazide alone in the absence of a low chloride; the normal chloride and bicarbonate argue against a contraction alkalosis from diuretics. The combination of refractory hypokalemia plus hypomagnesemia should prompt evaluation for renal magnesium wasting and for exogenous magnesium/potassium-losing agents.

The 'natural calm' powder is typically magnesium citrate - but magnesium citrate causes diarrhea and can lower magnesium if malabsorbed; more importantly, chronic use of magnesium-containing laxatives/supplements with a PPI is associated with hypomagnesemia (PPI-induced renal magnesium wasting). Hypomagnesemia causes refractory hypokalemia because low intracellular Mg opens ROMK channels and increases renal K wasting, so potassium will not correct until magnesium is repleted. Both hypokalemia and hypomagnesemia prolong the QT interval and predispose to torsades de pointes, explaining recurrent syncope/palpitations.

Additional testing: serum and urine magnesium, urine potassium, urine chloride, TSH, and a PPI review. Check serum calcium and PTH (hypomagnesemia can cause functional hypoparathyroidism). Obtain a 24-hour Holter or event monitor and repeat ECG after electrolyte repletion. Discontinue the PPI and the supplement, replete Mg (IV or oral depending on symptoms) and K, and recheck levels in 1-2 weeks.

2. The patient's magnesium is repleted and potassium normalizes. Two months later she returns with the same pattern while off the PPI. What is the next best diagnostic step?

Read the worked answer

Recurrent hypokalemia + hypomagnesemia off the offending agents suggests a primary renal tubular disorder or an inherited channelopathy. The next step is a 24-hour urine collection for magnesium, potassium, and calcium, plus a spot urine Mg/Cr ratio and fractional excretion of magnesium.

  • High urine Mg with low serum Mg = renal magnesium wasting (e.g., Gitelman syndrome, Bartter syndrome, aminoglycoside/cisplatin toxicity, or a genetic tubulopathy).
  • Low urine Mg with low serum Mg = extrarenal loss (GI) or poor intake.

In a normotensive adult with hypokalemic metabolic alkalosis and hypomagnesemia, Gitelman syndrome (SLC12A3 mutation, distal convoluted tubule) is the leading consideration; it typically shows hypocalciuria and low-normal blood pressure. Bartter syndrome usually presents earlier and with hypercalciuria. Order plasma renin and aldosterone (both elevated in Gitelman/Bartter) and consider genetic testing. Also review all medications including diuretics and laxatives, and screen for surreptitious diuretic use with a urine diuretic screen if the story is inconsistent.